The global cell analysis market was valued at approximately USD 31.59 billion in 2024 and is expected to grow to USD 55.3 billion by 2030, reflecting a compound annual growth rate (CAGR) of 10.03% from 2025 to 2030. This growth is largely driven by the rising incidence of chronic diseases, advancements in cell analysis technologies, and an increase in drug discovery initiatives.
Cell analysis has become a crucial tool in identifying potential therapies and treatments for chronic diseases. The escalating prevalence of conditions such as cardiovascular diseases, cancer, autoimmune disorders, and neurological issues is expected to heighten the demand for cell analysis. Notably, the American Cancer Society projects that over 2 million new cancer cases will be diagnosed in the U.S. in 2024.
Key Market Trends & Insights
The North American cell analysis market led the global market, holding a 40.13% share in 2024.
The U.S. cell analysis market is forecasted to experience substantial growth in the upcoming years.
In terms of product and service, the reagents and consumables segment captured the largest revenue share at 48.33% in 2024.
The flow cytometry technique dominated the market, representing 18.95% of revenue in 2024.
The pharmaceutical and biotechnology companies segment was the leading end-user, accounting for 39.99% of the market share in 2024.
Order a free sample PDF of the Cell Analysis Market Intelligence Study, published by Grand View Research.
Market Size & Forecast
2024 Market Size: USD 31.59 Billion
2030 Projected Market Size: USD 55.3 Billion
CAGR (2025-2030): 10.03%
North America: Largest market in 2024
Asia Pacific: Fastest growing market
Key Companies & Market Share Insights
Key players in the cell analysis industry are actively implementing various strategies to enhance their market presence and broaden the reach of their products and services. Initiatives such as expansion and partnerships are vital for driving market growth, positioning the industry for continued progress in the face of rising demand for innovative therapeutic solutions.
Key Players
Thermo Fisher Scientific, Inc.
Danaher
BD
Merck KGaA
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Miltenyl Biotech
Revvity
New England Biolabs
Avantor, Inc.
Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.
Conclusion
The cell analysis market is poised for significant growth, driven by the increasing prevalence of chronic diseases and advancements in technology. As the industry evolves, companies are focusing on strategic initiatives such as partnerships and expansions to enhance their market presence. This proactive approach not only strengthens their competitive edge but also ensures they can meet the rising demand for innovative therapies. With a robust CAGR and a strong foothold in key regions, the future of the cell analysis market looks promising, paving the way for breakthroughs in healthcare and drug discovery.